XML 76 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Infromation Supplemental Guarantor Information (Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities $ 22,090 $ 17,999
Cash flow from investing activities:    
(Loans to) repayments from affiliates 0 0
Capital expenditures (21,728) (13,156)
Proceeds from derivative instruments (367) 2,181
Proceeds from sale of assets 1,895 0
Other 3,057 0
Net cash used in investing activities (17,143) (10,975)
Cash flow from financing activities:    
Loans from (repayments to) affiliates   0
Short-term debt borrowings (994) (6,324)
Revolving Facility borrowings 75,000 66,000
Revolving Facility reductions (65,000) (52,500)
Principal payments on long term debt (92) (99)
Supply chain financing (9,455) (14,304)
Proceeds from exercise of stock options 82 132
Purchase of treasury shares (141) (181)
Proceeds from (Payments for) Other Financing Activities 918 (5,647)
Net cash provided by financing activities 318 (12,923)
Net (decrease) increase in cash and cash equivalents 5,265 (5,899)
Effect of exchange rate changes on cash and cash equivalents 171 (114)
Cash and cash equivalents at beginning of period 11,888 17,317
Cash and cash equivalents at end of period 17,324 11,304
Parent Company [Member]
    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities 496 455
Cash flow from investing activities:    
(Loans to) repayments from affiliates (1,355) (60)
Capital expenditures 0 0
Proceeds from derivative instruments 0 0
Proceeds from sale of assets 0  
Other 0  
Net cash used in investing activities (1,355) (60)
Cash flow from financing activities:    
Loans from (repayments to) affiliates   0
Short-term debt borrowings 0 0
Revolving Facility borrowings 0 0
Revolving Facility reductions 0 0
Principal payments on long term debt 0 0
Supply chain financing 0 0
Proceeds from exercise of stock options 82 132
Purchase of treasury shares (141) (181)
Proceeds from (Payments for) Other Financing Activities 918 (346)
Net cash provided by financing activities 859 (395)
Net (decrease) increase in cash and cash equivalents 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Guarantor Subsidiaries [Member]
    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities 31,748 14,863
Cash flow from investing activities:    
(Loans to) repayments from affiliates 0 0
Capital expenditures (16,486) (10,003)
Proceeds from derivative instruments (258) 495
Proceeds from sale of assets 714  
Other 0  
Net cash used in investing activities (16,030) (9,508)
Cash flow from financing activities:    
Loans from (repayments to) affiliates   60
Short-term debt borrowings (11) 2
Revolving Facility borrowings 30,000 26,000
Revolving Facility reductions (46,000) (32,500)
Principal payments on long term debt (32) (44)
Supply chain financing 0 0
Proceeds from exercise of stock options 0 0
Purchase of treasury shares 0 0
Proceeds from (Payments for) Other Financing Activities 0 (15)
Net cash provided by financing activities (14,688) (6,497)
Net (decrease) increase in cash and cash equivalents 1,030 (1,142)
Effect of exchange rate changes on cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 4,752 4,425
Cash and cash equivalents at end of period 5,782 3,283
Non-Guarantor Subsidiaries [Member]
    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities (10,154) 2,681
Cash flow from investing activities:    
(Loans to) repayments from affiliates 0 0
Capital expenditures (5,242) (3,153)
Proceeds from derivative instruments (109) 1,686
Proceeds from sale of assets 1,181  
Other 3,057  
Net cash used in investing activities (1,113) (1,467)
Cash flow from financing activities:    
Loans from (repayments to) affiliates   0
Short-term debt borrowings (983) (6,326)
Revolving Facility borrowings 45,000 40,000
Revolving Facility reductions (19,000) (20,000)
Principal payments on long term debt (60) (55)
Supply chain financing (9,455) (14,304)
Proceeds from exercise of stock options 0 0
Purchase of treasury shares 0 0
Proceeds from (Payments for) Other Financing Activities 0 (5,286)
Net cash provided by financing activities 15,502 (5,971)
Net (decrease) increase in cash and cash equivalents 4,235 (4,757)
Effect of exchange rate changes on cash and cash equivalents 171 (114)
Cash and cash equivalents at beginning of period 7,136 12,892
Cash and cash equivalents at end of period 11,542 8,021
Consolidating Entries and Eliminations [Member]
    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities 0 0
Cash flow from investing activities:    
(Loans to) repayments from affiliates 1,355 60
Capital expenditures 0 0
Proceeds from derivative instruments 0 0
Proceeds from sale of assets 0  
Other 0  
Net cash used in investing activities 1,355 60
Cash flow from financing activities:    
Loans from (repayments to) affiliates   (60)
Short-term debt borrowings 0 0
Revolving Facility borrowings 0 0
Revolving Facility reductions 0 0
Principal payments on long term debt 0 0
Supply chain financing 0 0
Proceeds from exercise of stock options 0 0
Purchase of treasury shares 0 0
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash provided by financing activities (1,355) (60)
Net (decrease) increase in cash and cash equivalents 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0